-
powerful AI companies, in democratic security, and analysis of the development of new forms of agentic and adversarial AI that could undermine democracy. The candidate will be based in Lancaster University’s
-
by the British Academy. Based in Bodleian Special Collections at the Weston Library, the successful applicant will contribute to the redevelopment of MLGB as a sustainable, open-access digital resource
-
team, the PhD student will support the development of discrete choice experiments in two countries, and agent-based modelling, as we plan to model how doctors make job choices among alternative hospitals
-
). Biologics are cell and protein-based therapies which are transforming medical outcomes: This spans insulin for diabetes, glucagon-like peptides for obesity, CAR-T cells for cancer and more. A key challenge is
-
. This stems from the two main styles of AI development over the last two decades. 'First Wave AI' is used to describe the rules/logic based AI used heavily in the 1990's and 2000's and still in wide use today